GlassScriptPhysician profile
Elyse Broucek
NPI 1770180960
$2,379.49
in general payments reported to CMS, 2019-2025
20 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.49 · 2023: $257 · 2024: $783 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,359.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $390.98 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $273.88 | 2025 | Dupixent, Libtayo |
| Genzyme Corporation | $262.63 | 2023-2025 | |
| Organon LLC | $217.59 | 2025 | Vtama |
| Ucb, INC. | $188.52 | 2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $164.18 | 2024 | Sotyktu |
| Amgen INC. | $129.47 | 2023-2025 | Otezla, Otezla, Enbrel |
| Dermavant Sciences, INC. | $125.95 | 2024 | Vtama |
| Lilly USA, LLC | $93.15 | 2024-2025 | Taltz, Ebglyss |
| Janssen Biotech, INC. | $91.38 | 2023-2025 | Tremfya |
| Botanix Sb INC | $84.39 | 2025 | Sofdra |
| Novartis Pharmaceuticals Corporation | $80.53 | 2025 | |
| Leo Pharma INC. | $75.06 | 2024-2025 | Adbry |
| Incyte Corporation | $65.69 | 2023-2025 | Opzelura |
| Biofrontera INC. | $35.39 | 2025 | Ameluz |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $31.25 | 2025 | Xolair |
| Lnhc, INC | $21.46 | 2025 | Zelsuvmi |
| Sanofi-Aventis U.S. LLC | $20.49 | 2021 | |
| Boston Scientific Corporation | $17.81 | 2024 | Lux-Dx Insertable Cardiac Monitor |
| Biowound Solutions, INC. | $9.69 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elyse Broucek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.